U-87MG ATCC

Summary

U-87MG ATCC is a cell line^[1]. It draws 22 Wikipedia views per month (cell_line category, ranking #11 of 37).^[2]

Key Facts

• U-87MG ATCC's instance of is recorded as cell line^[3].
• U-87MG ATCC's instance of is recorded as cancer cell line^[4].
• U-87MG ATCC's instance of is recorded as contaminated/misidentified cell line^[5].
• U-87MG ATCC's Freebase ID is recorded as /m/046wf4^[6].
• U-87MG ATCC's described by source is recorded as U87MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell line^[7].
• U-87MG ATCC's described by source is recorded as One Hundred and Twenty-Seven Cultured Human Tumor Cell Lines Producing Tumors in Nude Mice23^[8].
• U-87MG ATCC's described by source is recorded as Absence of HeLa cell contamination in 169 cell lines derived from human tumors^[9].
• U-87MG ATCC's described by source is recorded as Human tumor lines for cancer research^[10].
• U-87MG ATCC's described by source is recorded as Presence of glycogen and growth-related variations in 58 cultured human tumor cell lines of various tissue origins.^[11].
• U-87MG ATCC's described by source is recorded as Acute and persistent infection of human neural cell lines by human coronavirus OC43.^[12].
• U-87MG ATCC's described by source is recorded as Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines^[13].
• U-87MG ATCC's described by source is recorded as Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures^[14].
• U-87MG ATCC's described by source is recorded as Low-dose radiation hypersensitivity in human tumor cell lines: effects of cell-cell contact and nutritional deprivation^[15].
• U-87MG ATCC's described by source is recorded as Overexpressed Skp2 within 5p amplification detected by array-based comparative genomic hybridization is associated with poor prognosis of glioblastomas^[16].
• U-87MG ATCC's described by source is recorded as Molecular and phenotypic characterisation of paediatric glioma cell lines as models for preclinical drug development^[17].
• U-87MG ATCC's described by source is recorded as IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas^[18].
• U-87MG ATCC's described by source is recorded as A Genome-Wide Screen for Microdeletions Reveals Disruption of Polarity Complex Genes in Diverse Human Cancers^[19].
• U-87MG ATCC's described by source is recorded as Anti-invasive and antiangiogenic effects of MMI-166 on malignant glioma cells^[20].
• U-87MG ATCC's described by source is recorded as MAP Kinase-Interacting Kinase 1 Regulates SMAD2-Dependent TGF-β Signaling Pathway in Human Glioblastoma^[21].
• U-87MG ATCC's described by source is recorded as The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity^[22].
• U-87MG ATCC's described by source is recorded as DNA fingerprinting of glioma cell lines and considerations on similarity measurements.^[23].
• U-87MG ATCC's described by source is recorded as Dynamic DNA methylation across diverse human cell lines and tissues^[24].
• U-87MG ATCC's described by source is recorded as A mass spectrometric-derived cell surface protein atlas^[25].
• U-87MG ATCC's described by source is recorded as Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies^[26].
• U-87MG ATCC's described by source is recorded as Elucidating the cancer-specific genetic alteration spectrum of glioblastoma derived cell lines from whole exome and RNA sequencing^[27].

Why It Matters

U-87MG ATCC draws 22 Wikipedia views per month (cell_line category, ranking #11 of 37).^[2] It is known by 10 alternative names across languages and contexts.^[28]